147 related articles for article (PubMed ID: 26713410)
1. A Child With Dyserythropoietic Anemia and Megakaryocyte Dysplasia Due to a Novel 5'UTR GATA1s Splice Mutation.
Zucker J; Temm C; Czader M; Nalepa G
Pediatr Blood Cancer; 2016 May; 63(5):917-21. PubMed ID: 26713410
[TBL] [Abstract][Full Text] [Related]
2. Impaired human hematopoiesis due to a cryptic intronic
Abdulhay NJ; Fiorini C; Verboon JM; Ludwig LS; Ulirsch JC; Zieger B; Lareau CA; Mi X; Roy A; Obeng EA; Erlacher M; Gupta N; Gabriel SB; Ebert BL; Niemeyer CM; Khoriaty RN; Ancliff P; Gazda HT; Wlodarski MW; Sankaran VG
J Exp Med; 2019 May; 216(5):1050-1060. PubMed ID: 30914438
[TBL] [Abstract][Full Text] [Related]
3. Congenital dyserythropoietic anemia associated to a GATA1 mutation aggravated by pyruvate kinase deficiency.
Pereira J; Bento C; Manco L; Gonzalez A; Vagace J; Ribeiro ML
Ann Hematol; 2016 Sep; 95(9):1551-3. PubMed ID: 27342114
[No Abstract] [Full Text] [Related]
4. Repercussion of Megakaryocyte-Specific Gata1 Loss on Megakaryopoiesis and the Hematopoietic Precursor Compartment.
Meinders M; Hoogenboezem M; Scheenstra MR; De Cuyper IM; Papadopoulos P; Németh T; Mócsai A; van den Berg TK; Kuijpers TW; Gutiérrez L
PLoS One; 2016; 11(5):e0154342. PubMed ID: 27152938
[TBL] [Abstract][Full Text] [Related]
5. Loss of the Gata1 gene IE exon leads to variant transcript expression and the production of a GATA1 protein lacking the N-terminal domain.
Kobayashi E; Shimizu R; Kikuchi Y; Takahashi S; Yamamoto M
J Biol Chem; 2010 Jan; 285(1):773-83. PubMed ID: 19854837
[TBL] [Abstract][Full Text] [Related]
6. Pluripotent stem cells reveal erythroid-specific activities of the GATA1 N-terminus.
Byrska-Bishop M; VanDorn D; Campbell AE; Betensky M; Arca PR; Yao Y; Gadue P; Costa FF; Nemiroff RL; Blobel GA; French DL; Hardison RC; Weiss MJ; Chou ST
J Clin Invest; 2015 Mar; 125(3):993-1005. PubMed ID: 25621499
[TBL] [Abstract][Full Text] [Related]
7. Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation.
Freson K; Matthijs G; Thys C; Mariën P; Hoylaerts MF; Vermylen J; Van Geet C
Hum Mol Genet; 2002 Jan; 11(2):147-52. PubMed ID: 11809723
[TBL] [Abstract][Full Text] [Related]
8. Global transcriptome and chromatin occupancy analysis reveal the short isoform of GATA1 is deficient for erythroid specification and gene expression.
Chlon TM; McNulty M; Goldenson B; Rosinski A; Crispino JD
Haematologica; 2015 May; 100(5):575-84. PubMed ID: 25682601
[TBL] [Abstract][Full Text] [Related]
9. Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development.
Muntean AG; Crispino JD
Blood; 2005 Aug; 106(4):1223-31. PubMed ID: 15860665
[TBL] [Abstract][Full Text] [Related]
10. Chromatin occupancy and epigenetic analysis reveal new insights into the function of the GATA1 N terminus in erythropoiesis.
Ling T; Birger Y; Stankiewicz MJ; Ben-Haim N; Kalisky T; Rein A; Kugler E; Chen W; Fu C; Zhang K; Patel H; Sikora JW; Goo YA; Kelleher N; Zou L; Izraeli S; Crispino JD
Blood; 2019 Nov; 134(19):1619-1631. PubMed ID: 31409672
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and genetic heterogeneity arising from a novel substitution at amino acid position Val205 in GATA1 related X-linked thrombocytopenia with dyserythropoietic anemia.
Jamwal M; Aggarwal A; Sharma P; Bansal D; Maitra A; Das R
Blood Cells Mol Dis; 2020 Mar; 81():102391. PubMed ID: 31865264
[No Abstract] [Full Text] [Related]
12. A Novel GATA1 Variant in the C-Terminal Zinc Finger Compared with the Platelet Phenotype of Patients with A Likely Pathogenic Variant in the N-Terminal Zinc Finger.
Bastida JM; Malvestiti S; Boeckelmann D; Palma-Barqueros V; Wolter M; Lozano ML; Glonnegger H; Benito R; Zaninetti C; Sobotta F; Schilling FH; Morgan NV; Freson K; Rivera J; Zieger B
Cells; 2022 Oct; 11(20):. PubMed ID: 36291092
[TBL] [Abstract][Full Text] [Related]
13. GATA1 erythroid-specific regulation of SEC23B expression and its implication in the pathogenesis of congenital dyserythropoietic anemia type II.
Russo R; Andolfo I; Gambale A; De Rosa G; Manna F; Arillo A; Wandroo F; Bisconte MG; Iolascon A
Haematologica; 2017 Sep; 102(9):e371-e374. PubMed ID: 28550189
[No Abstract] [Full Text] [Related]
14. Close to unraveling the secrets of congenital dyserythropoietic anemia types I and II.
Iolascon A; Delaunay J
Haematologica; 2009 May; 94(5):599-602. PubMed ID: 19407313
[TBL] [Abstract][Full Text] [Related]
15. Inducible Gata1 suppression expands megakaryocyte-erythroid progenitors from embryonic stem cells.
Noh JY; Gandre-Babbe S; Wang Y; Hayes V; Yao Y; Gadue P; Sullivan SK; Chou ST; Machlus KR; Italiano JE; Kyba M; Finkelstein D; Ulirsch JC; Sankaran VG; French DL; Poncz M; Weiss MJ
J Clin Invest; 2015 Jun; 125(6):2369-74. PubMed ID: 25961454
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1 (G208R) mutation.
Dührsen U; Kratz CP; Flotho C; Lauenstein T; Bommer M; König E; Brittinger G; Heimpel H
Ann Hematol; 2011 Mar; 90(3):301-6. PubMed ID: 20922527
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delay.
Juban G; Sakakini N; Chagraoui H; Cruz Hernandez D; Cheng Q; Soady K; Stoilova B; Garnett C; Waithe D; Otto G; Doondeea J; Usukhbayar B; Karkoulia E; Alexiou M; Strouboulis J; Morrissey E; Roberts I; Porcher C; Vyas P
Haematologica; 2021 Apr; 106(4):1106-1119. PubMed ID: 32527952
[TBL] [Abstract][Full Text] [Related]
18. RAP-011 Rescues the Disease Phenotype in a Cellular Model of Congenital Dyserythropoietic Anemia Type II by Inhibiting the SMAD2-3 Pathway.
De Rosa G; Andolfo I; Marra R; Manna F; Rosato BE; Iolascon A; Russo R
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759740
[TBL] [Abstract][Full Text] [Related]
19. Synergistic roles of DYRK1A and GATA1 in trisomy 21 megakaryopoiesis.
Sit YT; Takasaki K; An HH; Xiao Y; Hurtz C; Gearhart PA; Zhang Z; Gadue P; French DL; Chou ST
JCI Insight; 2023 Oct; 8(23):. PubMed ID: 37906251
[TBL] [Abstract][Full Text] [Related]
20. Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1.
Del Vecchio GC; Giordani L; De Santis A; De Mattia D
Acta Haematol; 2005; 114(2):113-6. PubMed ID: 16103636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
